| Literature DB >> 24893046 |
Paula Ramos-Silva1, Jaap Kaandorp2, Frédéric Herbst3, Laurent Plasseraud4, Gérard Alcaraz5, Christine Stern4, Marion Corneillat5, Nathalie Guichard6, Christophe Durlet6, Gilles Luquet7, Frédéric Marin6.
Abstract
The scleractinian coral Acropora millepora is one of the most studied species from the Great Barrier Reef. This species has been used to understand evolutionary, immune and developmental processes in cnidarians. It has also been subject of several ecological studies in order to elucidate reef responses to environmental changes such as temperature rise and ocean acidification (OA). In these contexts, several nucleic acid resources were made available. When combined to a recent proteomic analysis of the coral skeletal organic matrix (SOM), they enabled the identification of several skeletal matrix proteins, making A. millepora into an emerging model for biomineralization studies. Here we describe the skeletal microstructure of A. millepora skeleton, together with a functional and biochemical characterization of its occluded SOM that focuses on the protein and saccharidic moieties. The skeletal matrix proteins show a large range of isoelectric points, compositional patterns and signatures. Besides secreted proteins, there are a significant number of proteins with membrane attachment sites such as transmembrane domains and GPI anchors as well as proteins with integrin binding sites. These features show that the skeletal proteins must have strong adhesion properties in order to function in the calcifying space. Moreover this data suggest a molecular connection between the calcifying epithelium and the skeletal tissue during biocalcification. In terms of sugar moieties, the enrichment of the SOM in arabinose is striking, and the monosaccharide composition exhibits the same signature as that of mucus of acroporid corals. Finally, we observe that the interaction of the acetic acid soluble SOM on the morphology of in vitro grown CaCO3 crystals is very pronounced when compared with the calcifying matrices of some mollusks. In light of these results, we wish to commend Acropora millepora as a model for biocalcification studies in scleractinians, from molecular and structural viewpoints.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24893046 PMCID: PMC4043741 DOI: 10.1371/journal.pone.0097454
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Skeleton morphology and microstructure.
(A) Skeletal fragments after treatment in NaOCl (5%, vol/vol) for 72 h prior to longitudinal and transversal cuts. Scanning electron microscopy images from the skeleton morphology: (B) Axial corallite, (C) Radial corallites, (D) Closer view into a radial corallite showing different septa. Polished and EDTA-etched sections from a transversal cut (E–G) and longitudinal cut (H–I). EMZ – early mineralization zone.
Figure 2Molecular composition of the skeletal organic matrix from A. millepora.
(A) Analysis of electrophoresis on gel after AgNO3 staining.(B) PVDF membrane revealed by autoradiography with 45Ca, calmodulin (CaM)was used as positive control. (C) Infrared absorption spectra of ASM and AIM fractions with assignment of the main peaks. MM – Molecular marker, ASM – Acid soluble matrix, AIM – Acid insoluble matrix.
Figure 3Quantification of neutral, aminated and acidic monosaccharides in the ASM (blue) and in the AIM (red) of A. millepora.
Samples were hydrolyzed with 2°C (4 h). (A) Total Wt. % in the skeletal organic matrix (SOM, either ASM or AIM) are indicated in the graph (bars). (B) Concentrations (ng/µg) and relative molar percentages are shown in the table for both matrices.
Characterization of the 36 skeletal organic matrix proteins (SOMPs).
| UniprotKB accession | Name (Abbrev.) | Number of residues | Mw | pI | Major | Putative PTM | Other sequence properties |
| number | (status) | aa (%) | |||||
| B3EWY6 | Skeletal acidic Asp-rich Protein 1 (SAARP 1) | 386 | 40.1 | 3.92 | Asp (20.4) | Glycosaminoglycan site (2), N-glycosylation (3), Phosphorylation: Ser (22), Thr (5), Tyr (3) | SP |
| B3EWY7 | Acidic skeletal organic matrix protein (Acidic SOMP) | 359 | 36.1 | 4.13 | Asp (9.9) | Glycosaminoglycan site (6), N-glycosylation (5), O-Fucosylation (1), Phosphorylation: Ser (18), Thr (5), Tyr (2) | SP |
| B3EWY8 | Skeletal acidic Asp-rich Protein 2 (SAARP2) | 390 (Fragment) | 42.4 | 4.24 | Asp (21.1) | Glycosaminoglycan site (2), N-glycosylation (3), Phosphorylation: Ser (15), Thr (6), Tyr (1) | SP |
| B3EWY9 | Mucin-like | 1594 (Fragment) | - | - | - | ASX hydroxylation (3), Glycosaminoglycan site (7), N-glycosylation (12), O-Fucosylation (1), Phosphorylation: Ser (47), Thr (25), Tyr (9) | TM [1531–1553] |
| B3EWZ0 | Secreted acidic protein 1 (Amil-SAP1) | 168 (Fragment NT) | - | - | - | Glycosaminoglycan site (4) N-glycosylation (1) Phosphorylation: Ser (7), Thr (4), Tyr (0) | SP |
| B3EWZ1 | 142 (Fragment CT) | - | - | - | Glycosaminoglycan site (2) N-glycosylation (1) Phosphorylation: Ser (4), Thr (0), Tyr (2) | TM [124–141], G[D,7]S repeat [139–168] | |
| B3EWZ2 | Uncharacterized skeletal organic matrix protein-8 (USOMP-8) | 214 | 20.9 | 5.26 | Ser (8.9) | Glycosaminoglycan site (2) N-glycosylation (3) | SP |
| B3EWZ3 | Coadhesin | 1675 (Fragment) | - | - | - | Peptide C-terminal amidation (1) Glycosaminoglycan site (5) Phosphorylation: Ser (60), Thr (30), Tyr (13) | TM [1361–1383] |
| B3EWZ4 | Secreted acidic protein 2 (Amil-SAP2) | 168 (Fragment) | - | - | - | Glycosaminoglycan site (6), Phosphorylation: Ser (11), Thr (2), Tyr (3) | SG[D,6]GD repeat |
| B3EWZ5 | MAM and LDL-receptor domain- containing protein 1 | 5145 (Fragment) | - | - | - | Glycosaminoglycan site (3), N-glycosylation (1), Phosphorylation:? | RGD motif |
| B3EWZ6 | MAM and LDL-receptor domain- containing protein 2 | 7311 (Fragment) | - | - | - | Glycosaminoglycan site (6), N-glycosylation (2), O-Fucosylation site (1), Phosphorylation:? | P[T,2] repeat [178–189], [P,2][T,2] repeat [2261–2271] |
| B3EWZ7 | Threonine-rich protein | 288 (Fragment) | - | - | - | Glycosaminoglycan site (2), N-glycosylation (10), Phosphorylation: Ser (9), Thr (30), Tyr (0) | SP |
| B3EWZ8 | Ectin | 400 (Fragment) | - | - | - | Glycosaminoglycan site (4), N-glycosylation (1), Phosphorylation: Ser (17), Thr (7), Tyr (5) | SP |
| B3EWZ9 | Hephaestin-like | 1114 | 122.0 | 5.83 | Gly (8.5) | Peptide C-terminal amidation (3), Glycosaminoglycan site (5), N-glycosylation (2), Phosphorylation: Ser (28), Thr (17), Tyr (14) | SP |
| B3EX00 | Uncharacterized skeletal organic matrix protein-1 (USOMP-1) | 448 (Fragment) | - | - | - | Glycosaminoglycan site (5), N-glycosylation (8), Phosphorylation: Ser (19), Thr (6), Tyr (0) | LCR [101–120, 318–344, 428–448] |
| B3EX01 | CUB domain-containing protein | 409 | 42.8 | 5.05 | Thr (13.6) | Glycosaminoglycan site (3), N-glycosylation (6), Phosphorylation: Ser (17), Thr (17), Tyr (5) | SP |
| B3EX02 | MAM and fibronectin- containing protein | 422 (Fragment) | - | - | - | Peptide C-terminal amidation (1), Glycosaminoglycan site (3), N-glycosylation (6), Phosphorylation: Ser (18), Thr (4), Tyr (5) | |
| B7W112 | Glu-rich protein | 522 | 58.3 | 3.96 | Glu (22.3) | Glycosaminoglycan site (1), Phosphorylation: Ser (35), Thr (5), Tyr (10) | SP |
| B7W114 | Cephalotoxin-like protein | 473 (Fragment) | - | - | - | Glycosaminoglycan site (5), N-glycosylation (1), Phosphorylation: Ser (16), Thr (3), Tyr (8) | SP |
| B7WFQ1 | Uncharacterized skeletal organic matrix protein-2 (USOMP-2) | 505 | 52.9 | 5.90 | Cys (10.5) | Peptide C-terminal amidation (1), Glycosaminoglycan site (7), N-glycosylation (7), Phosphorylation: Ser (12), Thr (6), Tyr (3) | SP |
| B8RJM0 | Uncharacterized skeletal organic matrix protein-3 (USOMP-3) | 433 (Fragment) | - | - | - | Glycosaminoglycan site (6), N-glycosylation (2), Phosphorylation: Ser (22), Thr (8), Tyr (5) | SP |
| B8UU51 | Galaxin 2 | 275 | 26.8 | 8.18 | Cys (11.8) | Glycosaminoglycan site (2), N-glycosylation (2), Phosphorylation: Ser (4), Thr (2), Tyr (3) | SP |
| B8UU59 | polycystic kidney disease 1-related skeletal organic matrix protein (PKD1-related protein) | 3029 (Fragment) | - | - | - | Peptide C-terminal amidation (2), Glycosaminoglycan site (45), N-glycosylation (46), O-Fucosylation site (2), Phosphorylation: Ser (130), Thr (37), Tyr (31) | SP |
| G8HTB6 | Zona pellucida domain-containing protein | 414 | 43.8 | 4.92 | Ser (10.3) | Glycosaminoglycan site (3), Phosphorylation: Ser (18), Thr (7), Tyr (7) | SP |
| B8UU74 | Uncharacterized skeletal organic matrix protein-4 (USOMP-4) | 204 (Fragment) | - | - | - | Phosphorylation: Ser (3), Thr (3), Tyr (1) | LCR |
| D9IQ16 | Galaxin | 338 | 32.7 | 5.15 | Cys (12.7) | Glycosaminoglycan site (1), N-glycosylation (1), Phosphorylation: Ser (7), Thr (1), Tyr (3) | SP |
| B8UU78 | EGF and laminin G domain-containing protein | 1124 | 123.8 | 6.38 | Gly (8.5) Ser (8.5) | ASX hydroxylation (1), Glycosaminoglycan site (16), N-glycosylation (3), Phosphorylation: Ser (42), Thr (14), Tyr (17) | TM [1056–1078], LCR [423–434, 1110–1121] |
| B8V7P3 | Putative carbonic anhydrase | 148 (Fragment) | - | - | - | Glycosaminoglycan site (1), Phosphorylation: Ser (2), Thr (2), Tyr (0) | |
| B8V7Q1 | Protocadherin-like | 4467 | 486.1 | 4.98 | Val (9.7) | Peptide C-terminal amidation (1), Glycosaminoglycan site (27), Phosphorylation? | SP |
| B8V7R6 | Collagen alpha-1 chain | 888 (Fragment) | - | - | - | Peptide C-terminal amidation (3), Glycosaminoglycan sites (17), N-glycosylation (3), Phosphorylation: Ser (36), Thr (9), Tyr (7) | LCR [98–114, 225–279, 302–331, 422–441, 459–489], G[P,2] repeat [609–621], NGR motif [413–415, 452–454], RGD [221–223] |
| B8V7S0 | CUB and peptidase domain-containing protein 1 | 435 (Fragment) | - | - | - | N-glycosylation (2), Phosphorylation: Ser (11), Thr (11), Tyr (6) | LCR [384–405] |
| B7T7N1 | MAM and fibronectin containing protein 2 | 112 (Fragment) | - | - | - | Glycosaminoglycan site (4), N-glycosylations (3), Phosphorylation: Ser (3), Thr (1), Tyr (1) | |
| B8VIV4 | CUB and peptidase domain-containing protein 2 | 389 (Fragment) | - | - | - | Phosphorylation: Ser (4), Thr (3), Tyr (5) | |
| B8VIU6 | Uncharacterized skeletal organic matrix protein-5 (USOMP-5) | 256 | 25.2 | 8.92 | Ser (11.9) | Glycosaminoglycan site (3), N-glycosylations (6), Phosphorylation: Ser (10), Thr (6), Tyr (1) | SP |
| B8VIW9 | Neuroglian-like | 1280 | 140.4 | 5.65 | Ser (8.0) | Peptide C-terminal amidation (2), Glycosaminoglycan site (2), Phosphorylation: Ser (58), Thr (29), Tyr (17) | SP |
| B8VIX3 | Uncharacterized skeletal organic matrix protein-6 (USOMP6) | 436 | 48.1 | 9.04 | Glu (14.4) | Peptide C-terminal amidation (1), N-glycosylations (4), Phosphorylation: Ser (19), Thr (9), Tyr (1) | SP |
| B8WI85 | Uncharacterized skeletal organic matrix protein-7 (USOMP7) | 422 | 44.3 | 9.26 | Val (9.0) | Glycosaminoglycan site (7), N-glycosylation (1), Phosphorylation: Ser (11), Thr (1), Tyr (10) | SP |
Computed parameters: molecular weight (Mw), isoelectric point (pI), most abundant amino acid (Major aa%), post-translational modifications (PTM) and other sequence features: signal peptide (SP), transmembrane domain (TM), glycosylphosphatidylinositol (GPI anchor), complexity regions (LCR), regions of biased composition, motifs and repeats.
*Properties calculated based on the primary sequence of the mature protein, i.e. without peptide signal.
Figure 4SEM images of CaCO3 crystals grown in vitro with the addition of different concentrations of ASM: (A) 0 µg.ml−1, (B) 0.1 µg.ml−1, (C) 1 µg.ml−1, (E) 5 µg.ml−1, (E) 10 µg.ml−1 and (F) 20 µg.ml−1.
(G) Corresponding FTIR(ATR) absorbance spectra on the whole precipitated for the following ASM concentrations: 0, 0.1, 1, 10 and 20 µg.ml−1.
Figure 5Raman spectra obtained from different crystals grown in vitro with the addition of different concentrations of ASM: (A) 0 µg.ml−1, (B) 0.1 µg.ml−1, (C) 1 µg.ml−1, (E) 5 µg.ml−1, (E) 20 µg.ml−1 and (F) 20 µg.ml−1.
The visible bands clearly distinguish calcite and vaterite.